Medical Countermeasures Coalition (MC2)
Advancing Public Health Security Through Sound Policy and Partnerships
The Medical Countermeasures Coalition (MC2) is committed to fostering innovation and collaboration. Therefore, we aim to enhance national health preparedness effectively. In addition, our mission aligns with guidelines from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO).
About Medical Countermeasures Coalition
Medical countermeasures (MCMs) are essential for addressing public health emergencies. For example, pandemics, bioterrorism, and natural disasters all require swift and effective responses. According to the CDC, MCMs include vaccines, antiviral drugs, and diagnostic tools.
To ensure these solutions are accessible, MC2 focuses on key areas:
- Policy Innovation: Because policies shape health security, we align with the U.S. Department of Health & Human Services (HHS).
- Public-Private Partnerships: Moreover, collaboration drives impactful innovation.
- Global Preparedness: Therefore, we support initiatives based on WHO recommendations.
Our Members
MC2 comprises organizations dedicated to building an effective medical countermeasure enterprise, fostering innovation, and enhancing public health preparedness.
Our Members
MC2 comprises organizations dedicated to building an effective medical countermeasure enterprise, fostering innovation, and enhancing public health preparedness.
Our Mission: Advancing Public Health and Security
The mission of the Medical Countermeasures Coalition (MC2) is clear. Therefore, the coalition focuses on prioritizing health security to prepare for public health emergencies. For example, MC2 works to develop and sustain medical countermeasures (MCMs), which include vaccines, medicines, and tools for diagnosis.
In addition, the coalition aligns with key guidelines from the Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health & Human Services (HHS). This ensures that its efforts address both national and global health priorities. Learn more about the Medical Countermeasures Coalition (MC2) and its role in enhancing public health resilience.
Driving Sound Policy and Public-Private Partnerships
MC2 enhances national public health security and emergency preparedness. Therefore, we:
- Support Domestic Manufacturing: Because reliable supply chains are critical, we promote local production as emphasized by Biomedical Advanced Research and Development Authority (BARDA).
- Facilitate Medical Innovation: Moreover, we encourage the development of vaccines, drugs, and therapies.
- Strengthen Partnerships: In addition, we collaborate across sectors to build a resilient medical countermeasure infrastructure.
